Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
14.36
+0.84 (6.21%)
At close: Oct 13, 2025, 4:00 PM EDT
14.36
0.00 (0.00%)
After-hours: Oct 13, 2025, 4:00 PM EDT
Tyra Biosciences Market Cap
Tyra Biosciences has a market cap or net worth of $765.35 million as of October 13, 2025. Its market cap has decreased by -37.98% in one year.
Market Cap
765.35M
Enterprise Value
475.10M
1-Year Change
-37.98%
Ranking
Category
Stock Price
$14.36
Market Cap Chart
Since the IPO on September 15, 2021, Tyra Biosciences's market cap has increased from $654.64M to $765.35M, an increase of 16.91%. That is a compound annual growth rate of 3.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2025 | 765.35M | 4.67% |
| Dec 31, 2024 | 731.18M | 22.61% |
| Dec 29, 2023 | 596.34M | 87.61% |
| Dec 30, 2022 | 317.87M | -44.42% |
| Dec 31, 2021 | 571.90M | -12.64% |
| Sep 15, 2021 | 654.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 748.25B |
| Johnson & Johnson | 459.32B |
| AbbVie | 407.19B |
| UnitedHealth Group | 321.06B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.73B |